Krystal Biotech, Inc.·4

Jul 1, 4:15 PM ET

ROSSI DINO A 4

4 · Krystal Biotech, Inc. · Filed Jul 1, 2022

Insider Transaction Report

Form 4
Period: 2022-06-30
ROSSI DINO A
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-30+6,8006,800 total
    Exercise: $65.66Exp: 2032-06-30Common Stock (6,800 underlying)
Footnotes (1)
  • [F1]The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.

Documents

1 file
  • 4
    wf-form4_165670651988931.xmlPrimary

    FORM 4